Document Detail


End-of-life options for patients with advanced heart failure.
MedLine Citation:
PMID:  20585999     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Heart failure is a progressive disease with significant morbidity and mortality, but prognostication often is difficult. Many of the evidence-based therapies for heart failure provide symptomatic benefit, but may have intolerable side effects for patients with advanced disease. At the end of life, there is evidence of varying strengths for pharmacologic and nonpharmacologic relief of common symptoms like dyspnea, fatigue, pain, and depression. Patients also may benefit from inotropic therapy, ventricular assist devices, and hospice care. It is important for physicians to encourage patients to formulate advance directives, including decisions about do not resuscitate orders and deactivation of implantable cardioverter-defibrillators and ventricular assist devices.
Authors:
Judith Z Goldfinger; Eric D Adler
Related Documents :
17437589 - Dislodgement of atrial lead of the crt-d system and its migration into the pocket prese...
19156239 - Clinical experience with the tandemheart percutaneous ventricular assist device as a br...
16624689 - Lvad-induced reverse remodeling: basic and clinical implications for myocardial recovery.
15511449 - Extracorporeal membrane oxygenation is superior to right ventricular assist device for ...
8889879 - Mechanisms of dynamic cardiomyoplasty: current concepts.
11044309 - Midterm follow-up of patients who underwent removal of a left ventricular assist device...
15298699 - Outcome after acute myocardial infarction: a comparison of patients seen by cardiologis...
12372679 - Positron emission tomography, echo-doppler, and exercise studies of functional capacity...
18780659 - Cardiac troponins and left ventricular hypertrophy in hemodialysis patients.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Current heart failure reports     Volume:  7     ISSN:  1546-9549     ISO Abbreviation:  Curr Heart Fail Rep     Publication Date:  2010 Sep 
Date Detail:
Created Date:  2010-07-19     Completed Date:  2010-10-29     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101196487     Medline TA:  Curr Heart Fail Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  140-7     Citation Subset:  IM    
Affiliation:
Department of Medicine, Mount Sinai Medical Center, One Gustave L. Levy Place, Box 1118, New York, NY 10029, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Cardiotonic Agents / therapeutic use
Defibrillators, Implantable
Heart Failure / complications,  therapy*
Heart-Assist Devices
Hospice Care
Humans
Palliative Care / methods*
Prognosis
Resuscitation Orders
Terminal Care / methods*
Chemical
Reg. No./Substance:
0/Cardiotonic Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Variation in the vitamin D receptor gene is not associated with risk of colorectal cancer in the Cze...
Next Document:  Quality-of-Life Measurements Versus Disease Activity in Systemic Lupus Erythematosus.